Specimen:
Collect
- Vaginal Swab in Aptima Kit-Multitest (Orange)
Submit
- Vaginal Swab in Aptima Kit-Multitest (Orange). Submit Ambient.
Special Handling
- Clinician collected and patient collected vaginal swabs specimens are acceptable.
Rejection Criteria
- Samples collected in any transport media other than Aptima
Samples collected after Aptima-tube expiration date
Male samples.
Transport tubes with incorrect or missing swabs.
Patients under 14 years of age
Stability
Ambient: 1 Month(s); Refrigerated: 1 Month(s); Frozen: 2 Month(s); Incubated: Unacceptable
Methodology
- Target Amplified Nucleic Acid Probe
Performed
Mon-Fri
Reported
1-3 Day(s)
CPT Codes
- 87481x2
- 87491
- 87591
- 87661
- 81513
- 87798
Interpretive Data
Please see report for interpretive data.
The Aptima Combo 2 Assay is a qualitative nucleic acid amplification test (NAAT) for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhea (GC).
The Aptima Trichomonas vaginalis Assay is qualitative nucleic acid amplification test (NAAT) for the detection of Trichomonas vaginalis.
The Aptima Mycoplasma genitalium assay is an in vitro nucleic acid amplification test (NAAT) for the qualitative detection of ribosomal RNA (rRNA) from Mycoplasma genitalium. It is intended for use as an aid in the diagnosis of M. genitalium urogenital infections in male and female patients suspected of M. genitalium infection.
The Aptima BV Assay is an in vitro nucleic acid amplification test that utilizes real time transcription mediated amplification (TMA) for the qualitative detection of RNA from bacteria associated with bacterial vaginosis (BV), including Lactobacillus (L.gasseri, L. crispatus, L. jensenii), Gardnerella vaginalis, and Atophobium vaginae.
The Aptima CV/TV Assay is an in vitro NAA test utilizing real time TMA for the qualitative detection of RNA associated with vulvovaginal candidiasis and trichomoniasis for the following organisms: Candida species group (C.albicans, C. tropicalis, C. parapsilosis, and C. dubliniensis), Candida glabrata, and Trichomonas vaginalis. Results should be interpreted in conjunction with clinical findings and should not preclude additional studies if findings do not correlate.
The Aptima Combo 2 Assay is a qualitative nucleic acid amplification test (NAAT) for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhea (GC).
The Aptima Trichomonas vaginalis Assay is qualitative nucleic acid amplification test (NAAT) for the detection of Trichomonas vaginalis.
The Aptima Mycoplasma genitalium assay is an in vitro nucleic acid amplification test (NAAT) for the qualitative detection of ribosomal RNA (rRNA) from Mycoplasma genitalium. It is intended for use as an aid in the diagnosis of M. genitalium urogenital infections in male and female patients suspected of M. genitalium infection.
The Aptima BV Assay is an in vitro nucleic acid amplification test that utilizes real time transcription mediated amplification (TMA) for the qualitative detection of RNA from bacteria associated with bacterial vaginosis (BV), including Lactobacillus (L.gasseri, L. crispatus, L. jensenii), Gardnerella vaginalis, and Atophobium vaginae.
The Aptima CV/TV Assay is an in vitro NAA test utilizing real time TMA for the qualitative detection of RNA associated with vulvovaginal candidiasis and trichomoniasis for the following organisms: Candida species group (C.albicans, C. tropicalis, C. parapsilosis, and C. dubliniensis), Candida glabrata, and Trichomonas vaginalis. Results should be interpreted in conjunction with clinical findings and should not preclude additional studies if findings do not correlate.
Components
- 1156 - BACT. VAGINOSIS
- 1158 - CANDIDA SPECIES
- 1159 - CANDIDA GLABRATA
- 1126 - N. GONORRHEA
- 1127 - CHLAMYDIA
- 5183 - M. GENITALIUM
- 2827 - TRICHOMONAS
- 1197 - SOURCE
Last Updated: November 20, 2024 @ 10:13 am
Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date. Updated test information can only be guaranteed by using this website.
